171 related articles for article (PubMed ID: 32165129)
1. Valproic acid affects fatty acid and triglyceride metabolism in HepaRG cells exposed to fatty acids by different mechanisms.
Grünig D; Szabo L; Marbet M; Krähenbühl S
Biochem Pharmacol; 2020 Jul; 177():113860. PubMed ID: 32165129
[TBL] [Abstract][Full Text] [Related]
2. Effect of the Catechol-O-Methyltransferase Inhibitors Tolcapone and Entacapone on Fatty Acid Metabolism in HepaRG Cells.
Grünig D; Felser A; Duthaler U; Bouitbir J; Krähenbühl S
Toxicol Sci; 2018 Aug; 164(2):477-488. PubMed ID: 29688484
[TBL] [Abstract][Full Text] [Related]
3. Impaired Hepatic Very Low-Density Lipoprotein Secretion Promotes Tumorigenesis and Is Accelerated with Fabp1 Deletion.
Newberry EP; Molitor EA; Liu A; Chong K; Liu X; Alonso C; Mato JM; Davidson NO
Am J Pathol; 2024 Jun; 194(6):958-974. PubMed ID: 38417694
[TBL] [Abstract][Full Text] [Related]
4. Induction of vesicular steatosis by amiodarone and tetracycline is associated with up-regulation of lipogenic genes in HepaRG cells.
Anthérieu S; Rogue A; Fromenty B; Guillouzo A; Robin MA
Hepatology; 2011 Jun; 53(6):1895-905. PubMed ID: 21391224
[TBL] [Abstract][Full Text] [Related]
5. The effects of fatty acids on apolipoprotein B secretion by human hepatoma cells (HEP G2).
Arrol S; Mackness MI; Durrington PN
Atherosclerosis; 2000 Jun; 150(2):255-64. PubMed ID: 10856517
[TBL] [Abstract][Full Text] [Related]
6. Coordinate transcriptional repression of liver fatty acid-binding protein and microsomal triglyceride transfer protein blocks hepatic very low density lipoprotein secretion without hepatosteatosis.
Spann NJ; Kang S; Li AC; Chen AZ; Newberry EP; Davidson NO; Hui ST; Davis RA
J Biol Chem; 2006 Nov; 281(44):33066-77. PubMed ID: 16950764
[TBL] [Abstract][Full Text] [Related]
7. Prevention of hepatic fibrosis with liver microsomal triglyceride transfer protein deletion in liver fatty acid binding protein null mice.
Newberry EP; Xie Y; Kennedy SM; Graham MJ; Crooke RM; Jiang H; Chen A; Ory DS; Davidson NO
Hepatology; 2017 Mar; 65(3):836-852. PubMed ID: 27862118
[TBL] [Abstract][Full Text] [Related]
8. Gamma delta tocotrienols reduce hepatic triglyceride synthesis and VLDL secretion.
Zaiden N; Yap WN; Ong S; Xu CH; Teo VH; Chang CP; Zhang XW; Nesaretnam K; Shiba S; Yap YL
J Atheroscler Thromb; 2010 Oct; 17(10):1019-32. PubMed ID: 20702976
[TBL] [Abstract][Full Text] [Related]
9. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
10. Perilipin 5 promotes hepatic steatosis in dairy cows through increasing lipid synthesis and decreasing very low density lipoprotein assembly.
Jia H; Li X; Liu G; Loor JJ; Bucktrout R; Sun X; Li G; Shu X; Dong J; Wang Y; Zuo R; Wang Z; Li X
J Dairy Sci; 2019 Jan; 102(1):833-845. PubMed ID: 30415861
[TBL] [Abstract][Full Text] [Related]
11. Drug-induced hepatic steatosis in absence of severe mitochondrial dysfunction in HepaRG cells: proof of multiple mechanism-based toxicity.
Allard J; Bucher S; Massart J; Ferron PJ; Le Guillou D; Loyant R; Daniel Y; Launay Y; Buron N; Begriche K; Borgne-Sanchez A; Fromenty B
Cell Biol Toxicol; 2021 Apr; 37(2):151-175. PubMed ID: 32535746
[TBL] [Abstract][Full Text] [Related]
12. MEK-ERK inhibition corrects the defect in VLDL assembly in HepG2 cells: potential role of ERK in VLDL-ApoB100 particle assembly.
Tsai J; Qiu W; Kohen-Avramoglu R; Adeli K
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):211-8. PubMed ID: 17038630
[TBL] [Abstract][Full Text] [Related]
13. Cholecystectomy increases hepatic triglyceride content and very-low-density lipoproteins production in mice.
Amigo L; Husche C; Zanlungo S; Lütjohann D; Arrese M; Miquel JF; Rigotti A; Nervi F
Liver Int; 2011 Jan; 31(1):52-64. PubMed ID: 21040411
[TBL] [Abstract][Full Text] [Related]
14. Human FABP1 T94A variant impacts fatty acid metabolism and PPAR-α activation in cultured human female hepatocytes.
McIntosh AL; Huang H; Storey SM; Landrock KK; Landrock D; Petrescu AD; Gupta S; Atshaves BP; Kier AB; Schroeder F
Am J Physiol Gastrointest Liver Physiol; 2014 Jul; 307(2):G164-76. PubMed ID: 24875102
[TBL] [Abstract][Full Text] [Related]
15. ApoB100 is required for increased VLDL-triglyceride secretion by microsomal triglyceride transfer protein in ob/ob mice.
Chen Z; Newberry EP; Norris JY; Xie Y; Luo J; Kennedy SM; Davidson NO
J Lipid Res; 2008 Sep; 49(9):2013-22. PubMed ID: 18519977
[TBL] [Abstract][Full Text] [Related]
16. Farnesol induces fatty acid oxidation and decreases triglyceride accumulation in steatotic HepaRG cells.
Pant A; Rondini EA; Kocarek TA
Toxicol Appl Pharmacol; 2019 Feb; 365():61-70. PubMed ID: 30611723
[TBL] [Abstract][Full Text] [Related]
17. Cathepsin B regulates hepatic lipid metabolism by cleaving liver fatty acid-binding protein.
Thibeaux S; Siddiqi S; Zhelyabovska O; Moinuddin F; Masternak MM; Siddiqi SA
J Biol Chem; 2018 Feb; 293(6):1910-1923. PubMed ID: 29259130
[TBL] [Abstract][Full Text] [Related]
18. Effects of palmitic acid on lipid metabolism homeostasis and apoptosis in goose primary hepatocytes.
Pan Z; Wang J; Tang H; Li L; Lv J; Xia L; Han C; Xu F; He H; Xu H; Kang B
Mol Cell Biochem; 2011 Apr; 350(1-2):39-46. PubMed ID: 21152956
[TBL] [Abstract][Full Text] [Related]
19. SREBP-1c overexpression induces triglycerides accumulation through increasing lipid synthesis and decreasing lipid oxidation and VLDL assembly in bovine hepatocytes.
Li X; Li Y; Yang W; Xiao C; Fu S; Deng Q; Ding H; Wang Z; Liu G; Li X
J Steroid Biochem Mol Biol; 2014 Sep; 143():174-82. PubMed ID: 24565561
[TBL] [Abstract][Full Text] [Related]
20. Oleic acid induces the novel apolipoprotein O and reduces mitochondrial membrane potential in chicken and human hepatoma cells.
Weijler AM; Schmidinger B; Kapiotis S; Laggner H; Hermann M
Biochimie; 2018 Apr; 147():136-142. PubMed ID: 29432786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
